Spark Therapeutics, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3737 Market Street, Suite 1300, Philadelphia, Pennsylvania (PA) 19104, United States (USA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3011194531 · DUNS 079498241
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIHuman Cellular, Tissue, and Gene Therapies2025-10-30
- NAIVaccines and Allergenic Products2022-03-04
- VAIHuman Cellular, Tissue, and Gene Therapies2022-03-04
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- voretigene neparvovec-rzylSpark Therapeutics, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.